In AML research, Tashiro et al. developed and preclinically evaluated CLL-1-CAR-T cells carrying an inducible caspase-9 (iCASP9) suicide system, whose activity can be reduced upon administration of a specific drug to limit toxicities against adult myeloid cells [76]. Here, CLEC12A is linked to acute myeloid leukemia.